Javascript must be enabled to continue!
Comparative evaluation of ondansetron, palonosetron, and dexamethasone for antiemetic prophylaxis in cesarean section under spinal anaesthesia
View through CrossRef
Background: Spinal anesthesia is the most common regional anesthesia used to provide surgical anesthesia for cesarean section. Nausea and vomiting are common symptoms experienced by patients undergoing cesarean section.
Aims and Objectives: The aim of this study was to assess and compare the efficacy of dexamethasone, ondansetron, and palonosetron in prevention of nausea and vomiting.
Materials and Methods: This prospective randomized study was conducted on total 90 patients undergoing cesarean section, divided in three groups of 30 patients each. Group O received 4 mg ondansetron i.v., Group P received palonosetron 075 mg i.v and Group D received 8 mg dexamethasone i.v. The incidence of nausea and vomiting was compared between the groups and side effects were assessed.
Results: Antiemetic prophylaxis reduced the overall incidence of nausea and vomiting. However, Palonosetron had a lower incidence of nausea and vomiting as compared to dexamethasone and ondansetron.
Conclusion: Our study concluded that Palonosetron had the lowest incidence of nausea and vomiting.
Pharmamedix India Publication Pvt Ltd
Title: Comparative evaluation of ondansetron, palonosetron, and dexamethasone for antiemetic prophylaxis in cesarean section under spinal anaesthesia
Description:
Background: Spinal anesthesia is the most common regional anesthesia used to provide surgical anesthesia for cesarean section.
Nausea and vomiting are common symptoms experienced by patients undergoing cesarean section.
Aims and Objectives: The aim of this study was to assess and compare the efficacy of dexamethasone, ondansetron, and palonosetron in prevention of nausea and vomiting.
Materials and Methods: This prospective randomized study was conducted on total 90 patients undergoing cesarean section, divided in three groups of 30 patients each.
Group O received 4 mg ondansetron i.
v.
, Group P received palonosetron 075 mg i.
v and Group D received 8 mg dexamethasone i.
v.
The incidence of nausea and vomiting was compared between the groups and side effects were assessed.
Results: Antiemetic prophylaxis reduced the overall incidence of nausea and vomiting.
However, Palonosetron had a lower incidence of nausea and vomiting as compared to dexamethasone and ondansetron.
Conclusion: Our study concluded that Palonosetron had the lowest incidence of nausea and vomiting.
Related Results
“A Comparative Study of Intravenous Ondansetron and Palonosetron for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy”
“A Comparative Study of Intravenous Ondansetron and Palonosetron for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy”
Background: Postoperative nausea and vomiting (PONV) remain among the most common and distressing complications following anesthesia and surgery, particularly after laparoscopic ch...
Torsades de Pointes Following Ondansetron Administration: A Case Report with literature review
Torsades de Pointes Following Ondansetron Administration: A Case Report with literature review
Abstract
Introduction
Ondansetron blocks human ether-à-go-go-related gene (hERG) potassium channels, causing QT prolongation and risk of torsades de pointes (TdP). Despite its wide...
Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy‐induced nausea and vomiting in patients with acute myelogenous leukemia
Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy‐induced nausea and vomiting in patients with acute myelogenous leukemia
AbstractBACKGROUND:Nausea and vomiting in patients with acute myelogenous leukemia (AML) can be from various causes, including the use of high‐dose cytarabine.METHODS:The authors c...
Use of palonosetron 0.25 mg IV daily and incidence of nausea and vomiting in patients undergoing bone marrow transplantation (BMT)
Use of palonosetron 0.25 mg IV daily and incidence of nausea and vomiting in patients undergoing bone marrow transplantation (BMT)
16510 Background: Preparative regimens for BMT are associated with a high incidence of nausea and vomiting, which can negatively affect quality of life. It is important to evaluat...
Pharmacological Management of Postoperative Nausea and Vomiting in Abdominal Surgery: Efficacy of Antiemetic Protocols
Pharmacological Management of Postoperative Nausea and Vomiting in Abdominal Surgery: Efficacy of Antiemetic Protocols
Background: Postoperative nausea and vomiting (PONV) are frequent and distressing complications following abdominal surgery, affecting up to seventy percent of high-risk patients. ...
Dexamethasone is cost-effective alternative to ondansetron in preventing Post-Operative Nausea and Vomiting
Dexamethasone is cost-effective alternative to ondansetron in preventing Post-Operative Nausea and Vomiting
Background: Postoperative nausea and vomiting (PONV) is a common complication of anesthesia and surgery. Numerous anti-emetics have been studied to prevent and treat PONV.
Methods...
Antiemetic Prophylaxis Practice and its Associated Factors Among Health Professionals in Referral Hospitals of North West Ethiopia: Multicenter Cross-Sectional Study
Antiemetic Prophylaxis Practice and its Associated Factors Among Health Professionals in Referral Hospitals of North West Ethiopia: Multicenter Cross-Sectional Study
ABSTRACT
Background:
The practice of antiemetic prophylaxis within the prevention and management of postoperative nausea...
Comparative study between Ondansetron and Dexamethasone in Post-operative Nausea Vomiting (PONV)
Comparative study between Ondansetron and Dexamethasone in Post-operative Nausea Vomiting (PONV)
Background: Postoperative nausea and vomiting (PONV) is a frequent and distressing complication following anaesthesia and surgery that negatively affects patient comfort, delays re...

